We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Constellation Healthcare Technologies | LSE:CHT | London | Ordinary Share | CMN SHS USD0.0001 (DI/REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 216.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCHT
RNS Number : 5752W
Constellation Healthcare Tech, Inc
28 April 2016
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL
28 April 2016
Constellation Healthcare Technologies, Inc.
("Constellation", "CHT" or "the Group")
Issue of Equity
Constellation Healthcare Technologies, Inc., the US based healthcare services company, announces that it has today issued 23,850 common shares of $0.0001 each in the capital of the company (the "Deferred Consideration Shares") in relation to the terms of the earn out included in the acquisition agreements for North East Medical Solutions LLC and NEMS West Virginia LLC (together "NEMS") on 31 March 2014.
Application has been made for the 23,850 common shares to be admitted to trading on AIM and it is expected that admission will become effective on 6 May 2016. Following admission, the total number of issued common shares in the Company will be 88,390,749. The Company does not hold any common shares in treasury and therefore this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
Enquiries:
Constellation Healthcare Technologies c/o Redleaf Polhill Paul Parmar, Chief Executive +44 (0)20 7382 4730 Officer finnCap - Nominated Adviser and Joint Broker Julian Blunt / Scott Mathieson +44 (0)20 7220 0500 Stifel - Joint Broker Jonathan Senior / Ben Maddison +44 (0)20 7710 7600 Redleaf Polhill - PR adviser +44 (0)20 7382 4730 Charlie Geller / Harriet Lynch constellation@redleafpr.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEQDLFLQZFXBBE
(END) Dow Jones Newswires
April 28, 2016 02:00 ET (06:00 GMT)
1 Year Constellation Healthcare Chart |
1 Month Constellation Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions